The company is engaged in scientific development, production and sales of products. Restet cream was developed in 2017 and became a real breakthrough in the field of cosmeceuticals and biotechnology, thanks to a unique substance - bacteriorhodopsin.
Bacteriorhodopsin is a retinal-containing protein that is isolated from the archaebacterium Halobacterium salinarum, which lives in salt marshes and lakes, where the salt concentration is 6 times higher than in sea water.
Thomas Cavalier-Smith, an English evolutionary biologist, professor of evolutionary biology at the University of Oxford, conducted studies of bacteriorhodopsin, which proved non-toxic and completely safe for the human body. The results were published in the article Cavalier-Smith T. "The neomuran origin of archaebacteria, the negibacterial root of the universal tree and bacterial megaclassification."
Cream "Restet"
• does not contain hormones, which is confirmed by spectral analysis
• contains natural bioactive components
• non-toxic and safe for the skin and the body as a whole
• not addictive
• hypoallergenic at 94-98%
• the result is noticeable within 7 days of use
The effectiveness of Restet has been proven by clinical studies at the I.M. Sechenov First Moscow State Medical University (Sechenov University).
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.restet.ru/
- Competitors
- Cornerstone Russia.
Restet Questions
Restet's website is https://www.restet.ru/
Restet's LinkedIn profile is https://www.linkedin.com/company/restet-cream
Restet has
1 employees.
View email and phone details for 1
employees at Restet.
Restet's industry is
Pharmaceutical Manufacturing
Restet's top competitors are
Cornerstone Russia.
Restet's categories are Pharmaceutical Manufacturing
Restet's founding year is 2017
